Untangling ligand induced activation and desensitization of G-protein-coupled receptors

Peter J Woolf1, Jennifer J Linderman

  • 1Department of Chemical Engineering, University of Michigan, Ann Arbor 48109, USA.

Biophysical Journal
|January 14, 2003
PubMed

Insights

Drug efficacy and receptor desensitization can be controlled by adjusting drug-receptor interactions. This study models G-protein-coupled receptor (GPCR) signaling to optimize drug design for longer therapeutic effects.

Area of Science:

  • Pharmacology
  • Computational Biology
  • Biophysics

Background:

  • Long-term drug treatment targeting G-protein-coupled receptors (GPCRs) often results in receptor desensitization, limiting therapeutic efficacy.
  • Understanding the mechanisms controlling GPCR desensitization is crucial for developing drugs with extended therapeutic windows.

Purpose of the Study:

  • To develop a mechanistic Monte Carlo model simulating early-stage GPCR signaling and desensitization.
  • To investigate how drug-specific parameters and cellular environment influence the balance between G-protein activation and receptor phosphorylation.

Main Methods:

  • Developed a mechanistic Monte Carlo model for GPCR signaling and desensitization.
  • Analyzed the impact of drug-receptor dissociation rate constant (k(off)) and drug efficacy (alpha) on signaling outcomes.
  • Assessed the influence of cellular environment factors like molecular diffusivity and G-protein inactivation rate.

Main Results:

  • Demonstrated that G-protein activation and receptor phosphorylation rates can be decoupled by modulating k(off) and alpha.
  • Identified an optimal drug profile (intermediate k(off), small alpha) for maximizing the ratio of G-protein activation to receptor phosphorylation (GARP).
  • Observed that cellular environment changes affect GARP values but not the fundamental shape of the GARP curve.

Conclusions:

  • Model predictions align with experimental data for various GPCRs, supporting the model's validity.
  • Suggests that drug desensitization properties can be rationally designed by tuning drug-receptor interaction kinetics.
  • Offers a framework for tailoring drug properties to achieve desired therapeutic lifetimes for GPCR-targeted therapies.

Related Concept Videos

GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
G Protein-coupled Receptors01:27

G Protein-coupled Receptors

G-protein-coupled receptors are ligand-binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that traverses the cell membrane seven times, creating intracellular and extracellular loops. The extracellular loops create a ligand-specific pocket which binds to neurotransmitters or hormones. The intracellular loops hold onto the G-protein.The G-protein, or guanine nucleotide-binding protein, is a large heterotrimeric complex. Its three subunits...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...